Coherus Oncology CHRS
NASDAQ CHRS
$0.99 -0.08 (-7.48%)
At close: Oct 16, 2026 · 4:00 PM EDT

Coherus Oncology (CHRS) Price to Earnings (2019 - 2026)

Updated

Coherus Oncology's (CHRS) Price to Earnings came in at 1.40 for Q1 2026, up 36.7% from the prior quarter.

Analysis

Coherus Oncology (CHRS) Price to Earnings (2019 - 2026) Analysis & Trends

For FY2025, Coherus Oncology's Price to Earnings stood at 1.02, down 81.7% from FY2024.

  • In prior years, Coherus Oncology's Price to Earnings was 5.60 in FY2024.
  • The Q1 2026 figure stands as the highest quarterly Price to Earnings since Q4 2024.
  • According to Business Quant data, Price to Earnings for the three prior quarters was 1.02 (Q4 2025), 1.23 (Q3 2025) and 0.47 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn
10 Coherus Oncology 155.59 Mn -480.55 Mn 10.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.40
Dec 31, 2025 1.02
Sep 30, 2025 1.23
Jun 30, 2025 0.47
Dec 31, 2024 5.60
Dec 31, 2020 9.53
Sep 30, 2020 8.17
Jun 30, 2020 7.06
Mar 31, 2020 7.91
Dec 31, 2019 14.10
API Access

Coherus Oncology Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=CHRS&period=max&api_key=YOUR_API_KEY